This EYPT PE ratio history page last updated 3/11/2024
Period | Price | GAAP | TTM | PE |
Q4 2023 3/7/2024 | 25.31 | -0.33 | -1.79 | NA | Q3 2023 11/1/2023 | 7.24 | -0.33 | -2.07 | NA | Q2 2023 8/2/2023 | 12.79 | -0.57 | -2.23 | NA | Q1 2023 5/3/2023 | 7.90 | -0.56 | -2.18 | NA | Q4 2022 3/2/2023 | 2.89 | -0.61 | -2.18 | NA | Q3 2022 11/2/2022 | 5.13 | -0.49 | -2.16 | NA | Q2 2022 8/3/2022 | 10.22 | -0.52 | -2.25 | NA | Q1 2022 5/4/2022 | 12.14 | -0.56 | -2.15 | NA | Q4 2021 3/3/2022 | 11.31 | -0.59 | -2.09 | NA | Q3 2021 11/3/2021 | 12.56 | -0.58 | -2.50 | NA | Q2 2021 8/4/2021 | 8.71 | -0.42 | -2.22 | NA | Q1 2021 5/5/2021 | 10.85 | -0.50 | -2.80 | NA | Q4 2020 3/4/2021 | 9.60 | -1.00 | -3.40 | NA | Q3 2020 11/5/2020 | 3.90 | -0.30 | -3.40 | NA | Q2 2020 8/5/2020 | 6.90 | -1.00 | -4.60 | NA | Q1 2020 5/6/2020 | 8.70 | -1.10 | -4.70 | NA | Q4 2019 3/5/2020 | 13.10 | -1.00 | -5.60 | NA | Q3 2019 11/7/2019 | 16.60 | -1.50 | -5.80 | NA | Q2 2019 8/7/2019 | 14.40 | -1.10 | -8.70 | NA | Q1 2019 5/8/2019 | 16.20 | -2.00 | -13.80 | NA | Q2 2019 3/14/2019 | 24.60 | -1.20 | -13.30 | NA | Q1 2019 11/6/2018 | 23.20 | -4.40 | -13.40 | NA | Q4 2018 9/12/2018 | 22.80 | -6.20 | -10.50 | NA | Q3 2018 5/8/2018 | 23.30 | -1.50 | -5.90 | NA | Q2 2018 2/7/2018 | 10.60 | -1.30 | -4.55 | NA | Q1 2018 11/7/2017 | 11.60 | -1.50 | -4.85 | NA | Q4 2017 9/11/2017 | 13.70 | -1.60 | -5.45 | NA | Q3 2017 5/4/2017 | 16.80 | -0.15 | -5.75 | NA | Q2 2017 2/7/2017 | 16.60 | -1.60 | -7.10 | NA | Q1 2017 11/7/2016 | 20.70 | -2.10 | -7.30 | NA | Q4 2016 9/12/2016 | 38.30 | -1.90 | -6.90 | NA | Q3 2016 5/5/2016 | 28.60 | -1.50 | -6.70 | NA | Q2 2016 2/8/2016 | 32.00 | -1.80 | -6.90 | NA | Q1 2016 11/5/2015 | 39.30 | -1.70 | -6.50 | NA | Q4 2015 9/9/2015 | 38.20 | -1.70 | 1.90 | 20.1 | Q3 2015 5/8/2015 | 39.30 | -1.70 | 2.20 | 17.9 | Q2 2015 2/5/2015 | 38.80 | -1.40 | 3.10 | 12.5 | Q1 2015 11/7/2014 | 35.20 | 6.70 | 3.20 | 11.0 | Q4 2014 9/9/2014 | 47.10 | -1.40 | -4.90 | NA | Q3 2014 5/13/2014 | 34.00 | -0.80 | -5.20 | NA | Q2 2014 2/7/2014 | 45.00 | -1.30 | -5.60 | NA | Q1 2014 11/12/2013 | 24.30 | -1.40 | -5.40 | NA | Q4 2013 9/25/2013 | 41.40 | -1.70 | -5.10 | NA | Q3 2013 5/13/2013 | 28.90 | -1.20 | -4.50 | NA | Q2 2013 2/6/2013 | 15.60 | -1.10 | NA | NA | Q1 2013 11/8/2012 | 14.20 | -1.10 | NA | NA | Q4 2012 9/24/2012 | 16.90 | -1.10 | NA | NA |
|
Period | Price | GAAP | Annualized | PE |
Q4 2023 3/7/2024 | 25.31 | -0.33 | -1.32 | NA | Q3 2023 11/1/2023 | 7.24 | -0.33 | -1.32 | NA | Q2 2023 8/2/2023 | 12.79 | -0.57 | -2.28 | NA | Q1 2023 5/3/2023 | 7.90 | -0.56 | -2.24 | NA | Q4 2022 3/2/2023 | 2.89 | -0.61 | -2.44 | NA | Q3 2022 11/2/2022 | 5.13 | -0.49 | -1.96 | NA | Q2 2022 8/3/2022 | 10.22 | -0.52 | -2.08 | NA | Q1 2022 5/4/2022 | 12.14 | -0.56 | -2.24 | NA | Q4 2021 3/3/2022 | 11.31 | -0.59 | -2.36 | NA | Q3 2021 11/3/2021 | 12.56 | -0.58 | -2.32 | NA | Q2 2021 8/4/2021 | 8.71 | -0.42 | -1.68 | NA | Q1 2021 5/5/2021 | 10.85 | -0.50 | -2.00 | NA | Q4 2020 3/4/2021 | 9.60 | -1.00 | -4.00 | NA | Q3 2020 11/5/2020 | 3.90 | -0.30 | -1.20 | NA | Q2 2020 8/5/2020 | 6.90 | -1.00 | -4.00 | NA | Q1 2020 5/6/2020 | 8.70 | -1.10 | -4.40 | NA | Q4 2019 3/5/2020 | 13.10 | -1.00 | -4.00 | NA | Q3 2019 11/7/2019 | 16.60 | -1.50 | -6.00 | NA | Q2 2019 8/7/2019 | 14.40 | -1.10 | -4.40 | NA | Q1 2019 5/8/2019 | 16.20 | -2.00 | -8.00 | NA | Q2 2019 3/14/2019 | 24.60 | -1.20 | -4.80 | NA | Q1 2019 11/6/2018 | 23.20 | -4.40 | -17.60 | NA | Q4 2018 9/12/2018 | 22.80 | -6.20 | -24.80 | NA | Q3 2018 5/8/2018 | 23.30 | -1.50 | -6.00 | NA | Q2 2018 2/7/2018 | 10.60 | -1.30 | -5.20 | NA | Q1 2018 11/7/2017 | 11.60 | -1.50 | -6.00 | NA | Q4 2017 9/11/2017 | 13.70 | -1.60 | -6.40 | NA | Q3 2017 5/4/2017 | 16.80 | -0.15 | -0.60 | NA | Q2 2017 2/7/2017 | 16.60 | -1.60 | -6.40 | NA | Q1 2017 11/7/2016 | 20.70 | -2.10 | -8.40 | NA | Q4 2016 9/12/2016 | 38.30 | -1.90 | -7.60 | NA | Q3 2016 5/5/2016 | 28.60 | -1.50 | -6.00 | NA | Q2 2016 2/8/2016 | 32.00 | -1.80 | -7.20 | NA | Q1 2016 11/5/2015 | 39.30 | -1.70 | -6.80 | NA | Q4 2015 9/9/2015 | 38.20 | -1.70 | -6.80 | NA | Q3 2015 5/8/2015 | 39.30 | -1.70 | -6.80 | NA | Q2 2015 2/5/2015 | 38.80 | -1.40 | -5.60 | NA | Q1 2015 11/7/2014 | 35.20 | 6.70 | 26.80 | 1.3 | Q4 2014 9/9/2014 | 47.10 | -1.40 | -5.60 | NA | Q3 2014 5/13/2014 | 34.00 | -0.80 | -3.20 | NA | Q2 2014 2/7/2014 | 45.00 | -1.30 | -5.20 | NA | Q1 2014 11/12/2013 | 24.30 | -1.40 | -5.60 | NA | Q4 2013 9/25/2013 | 41.40 | -1.70 | -6.80 | NA | Q3 2013 5/13/2013 | 28.90 | -1.20 | -4.80 | NA | Q2 2013 2/6/2013 | 15.60 | -1.10 | -4.40 | NA | Q1 2013 11/8/2012 | 14.20 | -1.10 | -4.40 | NA | Q4 2012 9/24/2012 | 16.90 | -1.10 | -4.40 | NA |
|
On this page we presented the EYPT PE Ratio History information for EyePoint Pharmaceuticals' stock.
The average EYPT PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 1.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average EYPT PE ratio history based on this TTM earnings result method is 15.4. Note: any PE calculations involving negative earnings were discarded as not meaningful.
Let's now compare this EYPT PE ratio history result, against the recent PE: when this page was posted on 3/8/2024, the most recent closing price for EYPT had been 24.40, and the most recent quarterly earnings result, annualized, was 26.8. Meanwhile, the most recent TTM earnings summed to 1.9. From these numbers, we calculate the recent EYPT PE on 3/8/2024 based on annualized quarterly EPS was 0.9. Based on EYPT's history, that recent PE is low relative to the historical average, with the recent PE 30.8% lower than the historical average PE across our data set for EyePoint Pharmaceuticals. Looking at the recent EYPT PE on 3/8/2024 based on TTM EPS, we calculate the ratio at 12.8. Based on EYPT's history, that recent PE is low relative to the historical average, with the recent PE 16.9% lower than the average PE across our EyePoint Pharmaceuticals data set with TTM EPS used in the calculation at each period.
For self directed investors doing their due diligence on EYPT or any other given stock, valuation analysis for EYPT
can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can
help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios
justify the current stock market value.
That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate
EyePoint Pharmaceuticals PE ratio history — or the PE history for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for
next earnings dates and also historical earnings surprises history for EYPT. Thanks for visiting, and the next
time you need to research EYPT PE Ratio History or the PE ratio history for another stock, we hope our site
will come to mind as your go-to PE ratio history research resource of choice.